Učitavanje...
P44. Activin A is novel circulating biomarker in lung cancer
BACKGROUND: Therapeutic decision making for the treatment of lung cancer is often a complex and challenging task. Biomarkers are urgently needed that can facilitate the early detection of these malignant diseases and can predict which therapeutic modality can significantly contribute to tumor contro...
Spremljeno u:
| Izdano u: | Transl Lung Cancer Res |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Pioneer Bioscience Publishing Company
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367750/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB056 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|